The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 17, 2017

Filed:

Jun. 01, 2012
Applicants:

Patricia K. Donahoe, Boston, MA (US);

David T. Maclaughlin, Gloucester, MA (US);

Jose Teixeira, Boston, MA (US);

Inventors:

Patricia K. Donahoe, Boston, MA (US);

David T. MacLaughlin, Gloucester, MA (US);

Jose Teixeira, Boston, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/574 (2006.01); A61K 31/416 (2006.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
G01N 33/57449 (2013.01); A61K 31/416 (2013.01); G01N 33/5073 (2013.01); G01N 2333/70585 (2013.01); G01N 2333/70596 (2013.01); G01N 2800/52 (2013.01);
Abstract

The present invention generally relates to methods, assays, compositions and kits related to a subpopulation of ovarian cancer stem cells which are selected or enriched by chemotherapeutic agents and inhibited by MIS (Mullerian Inhibiting Substance) and MIS mimetics. In particular, the present invention relates to a population of CD44+/CD24+/EpCam+/ECad− subpopulation of ovarian cancer stem cells. The present invention also provides methods to screen a subject with ovarian cancer to identify if they have an ovarian cancer comprising CD44+/CD24+/EpCam+/ECad− ovarian cancer stem cells, and methods to identify and enrich or isolate for such ovarian cancer cell populations.


Find Patent Forward Citations

Loading…